Peptide inhibitors of protein kinase C
US7507711B2 · kind B2 · utility
6Cited by
7References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 22, 2003 |
| Grant date | Mar 24, 2009 |
| Priority date | — |
| Expiry date | Jul 27, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
PKC V5 isozyme-specific peptides are described. The sequences and compositions comprising the sequences are useful for treating disease states associated with the PKC isozyme from which they are respectively derived. Methods of treatment, pharmaceutical formulations and methods of identifying compounds that mimic the activity of the peptides are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.